i-PRF and FDBA

Phase 2Biologic

KKrishnadevaraya College of Dental Sciences & Hospital

i-PRF and FDBA is one of 8 biologic programs targeting Bone. It is currently in Phase 2.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

BoneEnrolling by invitation

BonePhase 2

Enrolling by invitation

Competition

Competitive Landscape

11 competitors in Bone

#DrugCompanyPhaseTrials

Invanz

CCidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Preclinical

1 2

i-PRF and FDBA

KKrishnadevaraya College of Dental Sciences & Hospital

Phase 2

1 3

BOOST Cells

KKarolinska Institutet

Phase 2

1 4

Bone Marrow Aspirate Concentrate

MMassachusetts General Hospital

Preclinical

2 5

Platelet-Rich Fibrin (PRF)

FFederal University of São Paulo

Preclinical

1 6

Vertebral Bone Marrow Clot

IIstituto Ortopedico Rizzoli

Preclinical

1 7

Puregen Osteoprogenitor Cell Allograft

AAlphatec Spine, Inc.

Preclinical

1 8

Elelyso

SShaare Zedek Medical Center

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Bone1 trial

Radiographic Assessment of Bone Dimension Around Immediate Implants With FDBA and I-PRF vs FDBA Alone

Enrolling by invitation·KKrishnadevaraya College of Dental Sciences & Hospital·Phase 2·NCT06522321·20 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for i-PRF and FDBA. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — i-PRF and FDBA compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for i-PRF and FDBA. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Krishnadevaraya College of Dental Sciences & Hospital company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Biologic[2]
Highest Phase: Phase 2[1]
Company: KKrishnadevaraya College of Dental Sciences & Hospital

i-PRF and FDBA

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Bone1 trial

References

Drug Info

Quick Facts

Related News